SciELO - Scientific Electronic Library Online

 
vol.23 número10Uso y abuso de los catéteres intravenosos en las plantas de hospitalización convencionalInfección por el virus de Epstein-Barr y hepatitis aguda colestásica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Anales de Medicina Interna

versión impresa ISSN 0212-7199

Resumen

CASADO, J. M.  y  GRUPO ATICA et al. Neurohormonal blockade in patients with heart failure at discharge from hospital. An. Med. Interna (Madrid) [online]. 2006, vol.23, n.10, pp.478-482. ISSN 0212-7199.

With the objective to value the degree of fulfillment of the pharmacological processing in patients with heart failure was designed the study of therapeutic adherence in heart failure (ATICA). During the period of inclusion educational, social, demographic data have been obtained, personal antecedents, analytic and physical exploration of the patients. These data mentioned are the ones that are reflected in the present pilot study. The total of patients included is 554, the majority of which are women, the middle ages is advanced and they present a fraction of eyección conserved in more than the half. In the therapeutic plan only was collected information of groups with neurohormonal action and of great recognition in the processing of the heart failure. The most utilized pharmacological group are the IECA, nevertheless medicines as the espirolactona or the betablocker continue showing a worrying degree of infrautilización, although they present a greater prescription that in other series.

Palabras clave : Heart failure; Therapeutic adherence; Neurohormonal therapy.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons